The pandemic and the unprecedented success of mRNA-based COVID-19 vaccines have drawn attention and interest to mRNA technology, making it one of the most attractive technologies today. On October 5, 2021, join this technical symposium to hear from industry experts about the potential of mRNA technology, regulatory aspects, perspectives for a robust mRNA manufacturing process, efficient drug delivery, and the latest trends in the field.
By Tim Sandle, Ph.D., Bio Products Laboratory Ltd.
The process of assessing integrity of the filled syringe is generally more complex than the process of assessing glass vials, due to the presence of more sealing areas. This article looks at the broad requirement, together with a recent innovation for integrity testing based on X-rays.
The result of a recent partnership between Cytiva and Teva Pharmaceuticals is evidence that a successful tech transfer is possible only with effective communication, diligent project management, and a wide range of expertise.
In the realm of sterile injectables, sponsors come in a variety of sizes and with a range of experience levels. The same is true for CDMOs, and the dynamics of these outsourcing relationships has a huge influence on project success. Explore how a small or midsize biotech or pharma company can benefit from the experience and assistance provided by a CDMO.